Related Experiment Video
Updated: May 6, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
How good enough are the new therapies for lupus nephritis? A narrative review and a position paper
1Service de Rhumatologie, Cliniques universitaires Saint-Luc, Brussels, Belgium; Institut de Recherche Expérimentale et Clinique, UCLouvain, Belgium.
Abstract:
In this narrative review, the author, a privileged witness to exciting developments in the field of lupus nephritis over almost 4 decades, describes and comments on the new therapies that have recently become available, after years of trial failures. He stresses the use of combination therapy, now widely supported by expert recommendations to mitigate the risk of chronic kidney disease. He reviews the early days of cellular therapy and proposes some further lines of research.
Insights
New lupus nephritis therapies offer hope after years of failures. Combination treatments are recommended to prevent chronic kidney disease, with future research exploring cellular therapy.
Area of Science:
- Nephrology
- Immunology
- Rheumatology
Background:
- Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus, often leading to kidney failure.
- Therapeutic options for LN have historically been limited, with many clinical trials failing to yield effective treatments.
- Significant advancements have recently emerged, offering new hope for patients with this debilitating condition.
Purpose of the Study:
- To provide a narrative review of recent therapeutic developments in lupus nephritis.
- To comment on the efficacy and application of novel LN therapies.
- To emphasize the role of combination therapy in managing LN and preventing chronic kidney disease progression.
Main Methods:
- Narrative review of literature and clinical experience spanning nearly four decades.
- Analysis of recently approved and emerging therapies for lupus nephritis.
- Discussion of expert recommendations regarding combination therapy and future research directions.
Main Results:
- Several new therapies have become available for lupus nephritis following numerous trial failures.
- Combination therapy is increasingly recommended to mitigate the risk of chronic kidney disease.
- Early cellular therapy approaches are reviewed, with potential for future research.
Conclusions:
- Recent therapeutic advancements represent a significant breakthrough in lupus nephritis management.
- Combination therapy is crucial for improving long-term renal outcomes in LN patients.
- Further research, particularly in cellular therapy, is warranted to enhance treatment strategies for lupus nephritis.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

